Krystal Biotech, Inc. KRYS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s short-term investments?
- Krystal Biotech, Inc. (KRYS) reported short-term investments of $322.09M in Q1 2026.
- How has Krystal Biotech, Inc.'s short-term investments changed year-over-year?
- Krystal Biotech, Inc.'s short-term investments increased by 4.5% year-over-year, from $308.08M to $322.09M.
- What is the long-term trend for Krystal Biotech, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s short-term investments has grown at a 156.4% compound annual growth rate (CAGR), from $2.99M to $331.49M.
- What does short-term investments mean?
- Investments that can be easily converted to cash within one year.
- How do you interpret short-term investments?
- An increase indicates effective cash management and potential future funding for operations, while a decrease may signal cash usage for R&D or operations.
- How does short-term investments compare across companies?
- Common in capital-intensive industries; peers often hold these to offset inflation on idle cash reserves.